PharmTech Talk

Feb 11, 2016
Vaccine R&D has grown exponentially in recent years, spurred by ethical and medical needs to combat lethal infectious outbreaks and increased funding from public and private agencies and organizations.
Feb 10, 2016
There was scant praise from the medical community for the eighth and final budget plan from the Obama administration.
Feb 04, 2016
In a hearing held on Feb. 4, 2016, executives from Valeant and Turing had a hard time explaining their rationales for exorbitant price hikes of older drugs.
Feb 01, 2016
Can the feds negotiate Medicare Part D prices?
Jan 29, 2016
FDA and industry seek a more consistent, flexible CMC review process for breakthrough therapies.
Jan 04, 2016
More “me-betters” and more focused breakthroughs could enhance new drug development.
Dec 28, 2015
The FDA program that encourages biopharma companies to develop new treatments for rare and neglected diseases has been in the spotlight recently.
Dec 17, 2015
Janet Woodcock, director of the Center for Drug Evaluation, highlights FDA's priority list for 2016.
Dec 14, 2015
The use of drug compounding facilities to produce over-priced generic drugs raises quality and regulatory questions.
Dec 14, 2015
Pharmaceutical Technology
This month marks the death of a pragmatic, original thinker who helped make PAT and QbD a reality at more pharmaceutical facilities throughout the world.
lorem ipsum